Aggressive variants of papillary thyroid carcinoma

Area of Science:

• Endocrinology
• Oncology
• Surgical Pathology

Background:

• Well-differentiated papillary thyroid cancer (PTC) has several histologic variants.
• Some variants, like tall cell and diffuse sclerosing, are suspected to be more aggressive.

Purpose of the Study:

• To evaluate the independent prognostic significance of aggressive histologic variants of papillary thyroid cancer.
• To clarify the relationship between histologic variants, clinical features, and patient outcomes.

Main Methods:

• Review of cases with well-differentiated papillary thyroid cancer, focusing on histologic variants.
• Multivariate analysis to assess predictors of outcome, including histologic subtype and clinical staging features.

Main Results:

• Evidence for histologic subtype as an independent predictor of outcome is weak.
• Aggressive variants often present with adverse prognostic factors (high grade, extracapsular spread, large size, metastasis).
• Prognosis is strongly correlated with the presence of these adverse features, not solely the variant.

Conclusions:

• Clinical decisions for papillary thyroid cancer should prioritize overall disease stage and risk factors over histologic variant alone.
• Aggressive variants warrant heightened surgical consideration, including extensive resection and radioactive iodine therapy.
• The tall cell variant may be refractory to radioactive iodine but potentially responsive to BRAF-targeted therapy.